These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4329095)

  • 21. The effects of prolonged ACTH or corticosteroid therapy in children on growth and on pituitary-adrenal and pituitary function.
    Friedman M; Greenwood FC
    Proc R Soc Med; 1967 Sep; 60(9):910-1. PubMed ID: 4293430
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of 6-dehydro-16-methylene-hydrocortisone and dexamethasone on hypothalamo-hypophyseal-adrenal cortex-system].
    Berthold K
    Arzneimittelforschung; 1971 Oct; 21(10):1510-2. PubMed ID: 4333356
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of trimcinolone effect on inhibiting the corticotropic activity of the hypophysis].
    Pawlikowski T; Zieleniewski J; Muszyńska B; Jezewska-Musial M
    Endokrynol Pol; 1973; 24(4):329-32. PubMed ID: 4356940
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Effects of hypothalamic extracts and corticosteroids on pituitary adrenocorticotrophic activity.
    Buckingham JC; Hodges JR
    J Endocrinol; 1976 Jun; 69(3):34P. PubMed ID: 181513
    [No Abstract]   [Full Text] [Related]  

  • 25. Site of the inhibiting action of diphenylhydantoin on the release of corticotrophin in epileptic patients.
    Rinne UK
    Med Pharmacol Exp Int J Exp Med; 1967; 17(5):409-16. PubMed ID: 4299898
    [No Abstract]   [Full Text] [Related]  

  • 26. [Steroid-induced adrenal gland hypofunction. Pathogenesis, clinical aspects, diagnosis, prevention and therapy].
    Bethge H
    Klin Wochenschr; 1970 Mar; 48(6):317-32. PubMed ID: 4329164
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypothalamo-hypophyso-adrenal activity under corticotherapy. Comparative study of ACTH, Synacthene, metopirone, lysine-vasopressin and pyrogen tests].
    Bloch-Michel H; Gorins A; Thevenet M
    Ann Endocrinol (Paris); 1969; 30(3):470-9. PubMed ID: 4311601
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The thyroid gland, adrenal cortex and gonads--with reference to the metabolism of thyroid hormones, the adrenal cortex and sex steroid hormones].
    Ibayashi H
    Saishin Igaku; 1967 Jul; 22(7):1437-55. PubMed ID: 4295654
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticosteroids and adrenal function.
    JAMA; 1969 Sep; 209(11):1713. PubMed ID: 5820170
    [No Abstract]   [Full Text] [Related]  

  • 31. [Endocrinological test of the pituitary-adrenal cortex system].
    Miyake T; Iwai K; Tamura Y; Yoshimi T; Mitsuse N
    Horumon To Rinsho; 1966 Feb; 14(2):99-104. PubMed ID: 4289674
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with massive doses of synthetic corticoids and hypothalamopituitary adrenocortical function with reference to acute leukemia].
    Nakamura M
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):1044-58. PubMed ID: 4298015
    [No Abstract]   [Full Text] [Related]  

  • 33. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. I. Adrenocorticotropic and pituitary responsiveness following long-term intermittent administration.
    Benos SA; Koutsoukos A; Braouzi H; Georgopoulos A; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):165-77. PubMed ID: 4314189
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of short-term administration of synthetic corticosteroids on pituitary-adrenal function.
    Fotherby K; Warren RJ; Harcus AW
    Arzneimittelforschung; 1974 Jan; 24(1):97-9. PubMed ID: 4406120
    [No Abstract]   [Full Text] [Related]  

  • 35. Corticotrophin secretion capacity in multiple sclerosis.
    Rinne UK
    Eur Neurol; 1968; 1(4):221-33. PubMed ID: 4301627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of intra-articular and intraspinal corticotherapy on the hypophyso-adrenal axis].
    Oliver C; Lapousse JC; Maestracci D; d' Omezon Y; Vague P; Hawthorn E
    Rhumatologie; 1971 Nov; 23(9):323-30. PubMed ID: 4333924
    [No Abstract]   [Full Text] [Related]  

  • 37. [The importance of studying steroid and hypophyseal hormone excretion in patients with dyshormonal tumors].
    Sharoukhova KS
    Vestn Akad Med Nauk SSSR; 1968; 23(3):63-8. PubMed ID: 5754742
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone regulation and hypothalamic-pituitary-adrenal function in anorexia nervosa.
    Neri V; Ambrosi B; Beck-Peccoz P; Travaglini P; Faglia G
    Folia Endocrinol; 1972 Apr; 25(2):143-52. PubMed ID: 4353815
    [No Abstract]   [Full Text] [Related]  

  • 39. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis.
    Jasani MK; Boyle JA; Greig WR; Dalakos TG; Browning MC; Thompson A; Buchanan WW
    Q J Med; 1967 Jul; 36(143):261-76. PubMed ID: 6049762
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypothalamo-pituitary function in Pickwickian syndrome.
    Smirne S; Reschini E; Giustina G
    Bull Physiopathol Respir (Nancy); 1972; 8(5):1021-8. PubMed ID: 4657861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.